Your browser doesn't support javascript.
loading
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle, Nana; Borde, Julika; Weber-Lassalle, Konstantin; Horváth, Judit; Niederacher, Dieter; Arnold, Norbert; Kaulfuß, Silke; Ernst, Corinna; Paul, Victoria G; Honisch, Ellen; Klaschik, Kristina; Volk, Alexander E; Kubisch, Christian; Rapp, Steffen; Lichey, Nadine; Altmüller, Janine; Lepkes, Louisa; Pohl-Rescigno, Esther; Thiele, Holger; Nürnberg, Peter; Larsen, Mirjam; Richters, Lisa; Rhiem, Kerstin; Wappenschmidt, Barbara; Engel, Christoph; Meindl, Alfons; Schmutzler, Rita K; Hahnen, Eric; Hauke, Jan.
Afiliación
  • Weber-Lassalle N; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Borde J; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Weber-Lassalle K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Horváth J; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Niederacher D; Department of Gynaecology and Obstetrics, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Arnold N; Institute of Clinical Molecular Biology, Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Kaulfuß S; Institute of Human Genetics, University Medical Center, Georg August University, Goettingen, Germany.
  • Ernst C; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Paul VG; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Honisch E; Department of Gynaecology and Obstetrics, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Klaschik K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Volk AE; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kubisch C; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rapp S; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Lichey N; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Altmüller J; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Lepkes L; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Pohl-Rescigno E; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Thiele H; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Nürnberg P; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Larsen M; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Richters L; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Rhiem K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Wappenschmidt B; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Engel C; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Meindl A; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 34, 50931, Cologne, Germany.
  • Schmutzler RK; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Hahnen E; LIFE Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
  • Hauke J; Department of Gynaecology and Obstetrics, University of Munich, Campus Großhadern, Munich, Germany.
Breast Cancer Res ; 21(1): 55, 2019 04 29.
Article en En | MEDLINE | ID: mdl-31036035
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mutación de Línea Germinal / Predisposición Genética a la Enfermedad / Proteínas Supresoras de Tumor / Ubiquitina-Proteína Ligasas / Mutación con Pérdida de Función Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mutación de Línea Germinal / Predisposición Genética a la Enfermedad / Proteínas Supresoras de Tumor / Ubiquitina-Proteína Ligasas / Mutación con Pérdida de Función Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article